APA (7th ed.) Citation

R, L., P, V., FS, D. L., S, S., M, M., & G, B. (2022). Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue. Frontiers in oncology, 12, 877380. https://doi.org/10.3389/fonc.2022.877380

Chicago Style (17th ed.) Citation

R, Loria, Vici P, Di Lisa FS, Soddu S, Maugeri-Saccà M, and Bon G. "Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue." Frontiers in Oncology 12 (2022): 877380. https://doi.org/10.3389/fonc.2022.877380.

MLA (9th ed.) Citation

R, Loria, et al. "Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue." Frontiers in Oncology, vol. 12, 2022, p. 877380, https://doi.org/10.3389/fonc.2022.877380.